Bioprocessing & Cell Culture 2018
21st - 22nd May 2018, Hong Kong, China
This meeting explores today’s evolving strategies and technologies for improving mammalian cell cultivation, including omics technologies and synthetic biology.
Industry experts offer insights into optimizing conditions as well as cell biology in an effort to improve yield, while also addressing the future of cell culture in an expanding market where standards of quality continue to rise.
Cellular therapies hold the potential to revolutionize health care for a variety of diseases. However, the limitations lie in the productivity of engineered cells and the safe, efficacious and cost effective transformation of commercialized cell therapies. The industry is yet to address certain gaps relating to these limitations that will facilitate clinical and commercial success of these therapies.
The aim of the BioTech Pharma Summit: Bioprocessing & Cell Culture 2018 is is to assess the risks and benefits of the cell culture and cell therapy bio-manufacturing by focusing in particular on the feasibility of process automation: its impact on regulatory compliance and return on investment.